Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 5.23M | $4.85B | 8.45% | +240.4K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.68M | $2.48B | 4.33% | -696.9K | 2026-06-30 |
| Jupiter Topco LLC | 2.47M | $2.29B | 4.00% | -- | 2026-06-30 |
| Capital World Investors | 2.20M | $2.04B | 3.55% | -56.4K | 2026-06-30 |
| Artisan Partners Limited Partnership | 1.51M | $1.40B | 2.44% | +40.8K | 2026-06-30 |
| Avoro Capital Advisors LLC | 1.00M | $927.0M | 1.62% | -- | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 930.5K | $863.0M | 1.50% | -90.9K | 2026-06-30 |
| BlackRock, Inc. | 777.2K | $721.0M | 1.26% | -31.1K | 2026-06-30 |
| RTW INVESTMENTS, LP | 709.4K | $658.0M | 1.15% | -- | 2026-06-30 |
| MORGAN STANLEY | 643.1K | $596.0M | 1.04% | +82.4K | 2026-06-30 |
